#6100
Aspergillus
fumigatus IgG ELISA
ELISA kit for the diagnosis of human aspergillosis
Lot 2315A (Expiry date: 02.12.2024)
Production date : 03.04.2023
Results of quality control 3 (after
12 months), date: 27.03.2024
No serum blank (average) : 0.129
Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
-0.014 |
0.018 |
-0.016 |
0.012 |
0.000 |
0 |
Negative control serum
(N° 6100-06) |
0.028 |
0.079 |
0.053 |
0.090 |
0.063 |
3 |
Weak positive serum
(N° 6100-07) |
0.532 |
0.561 |
0.501 |
0.508 |
0.526 |
24 |
Positive control
serum
(N° 6100-08) |
2.151 |
2.234 |
2.194 |
2.304 |
2.221 |
100 |
Validation criteria:
|
Criterion |
Measure |
Valid |
Absorbance of positive serum 6100-08 |
> 1.200 |
2.221 |
Yes |
Absorbance of weak positive serum 6100-07, as % of positive serum
|
> 11 % |
24 % |
Yes |
Absorbance of negative serum 6100-06, as % of positive serum |
< 8 % |
3 % |
Yes |
Absorbance of no serum blank |
< 0.350 |
0.129 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bātiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|